<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Med.</journal-id><journal-title-group><journal-title>Frontiers in Medicine</journal-title></journal-title-group><issn pub-type="epub">2296-858X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098088</article-id><article-id pub-id-type="doi">10.3389/fmed.2025.1538832</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine</subject><subj-group><subject>Clinical Trial</subject></subj-group></subj-group></article-categories><title-group><article-title>Physiological effects of bi-level high-flow nasal cannula in healthy individuals: a proof of concept trial</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Huh</surname><given-names>Jin Won</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/2261470/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Seo</surname><given-names>Woo Jung</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1757921/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ahn</surname><given-names>Jee Hwan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Su Yeon</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Hee Jung</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Seo</surname><given-names>Ga Jin</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Eun Young</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Min Kyung</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lim</surname><given-names>Chae-Man</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff><aff id="aff2"><sup>2</sup><institution>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine</institution>, <addr-line>Goyang</addr-line>, <country>Republic of Korea</country></aff><aff id="aff3"><sup>3</sup><institution>Respiratory Care Services, Asan Medical Center</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Habib Md Reazaul Karim, All India Institute of Medical Sciences, India</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hao Qin, Second Military Medical University, China</p><p>Mohamad El-Khatib, American University of Beirut Medical Center, Lebanon</p><p>Dibakar Sahu, All India Institute of Medical Sciences Raipur, India</p></fn><corresp id="c001">*Correspondence: Chae-Man Lim, <email>cmlim@amc.seoul.kr</email></corresp><fn fn-type="equal" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1538832</elocation-id><history><date date-type="received"><day>03</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>26</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Huh, Seo, Ahn, Lee, Suh, Seo, Kim, Jang and Lim.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Huh, Seo, Ahn, Lee, Suh, Seo, Kim, Jang and Lim</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Background</title><p>High-flow nasal cannula (HFNC) delivers a continuous, unidirectional high flow of oxygen (Uniflow) throughout the respiratory cycle. Despite its positive pressure effects in the nasopharynx, the persistent high flow during expiration imposes additional work of breathing and disrupts the patient&#x02019;s neural respiratory cycle. We devised a bi-level high-flow system (Biflow) allowing separate flow rate adjustments for inspiration and expiration.</p></sec><sec><title>Methods</title><p>We conducted a randomized crossover pilot study which we included healthy volunteer at ASAN Medical Center (April 2021 to June 2021). The data of 12 healthy volunteers (7 male, 5 female, average age 46.3 years) were analyzed. For Uniflow, flow settings of 30 (U30), 40 (U40), and 50 (U50) L/min were tested. In the Biflow, inspiratory flow rates were matched to the Uniflow settings, while expiratory flow rates varied from 10 to 30 L/min. The sequence of each flow (Uniflow vs. Biflow) was randomized and each flow setting was maintained for 3 min. Physiologic parameters, nasopharyngeal pressure-time product (N-PTP) as an energy cost proxy, end-expiratory lung impedance (EELI), and participant comfort were assessed.</p></sec><sec><title>Results</title><p>Uniflow decreased respiratory rate and elongated expiratory time compared to natural breathing. However, these effects were less pronounced during Biflow. Compared with the Uniflow, both expiratory and inspiratory N-PTP were lower during the Biflow. Transcutaneous CO<sub>2</sub> was lower during the Biflow compared with natural breathing or Uniflow. EELI did not differ between modes. All participants completed the study protocol without side effects.</p></sec><sec><title>Conclusion</title><p>In healthy participants, compared with the conventional HFNC (Uniflow), Biflow showed less interference with the natural respiratory cycle of the participants. Compared with Uniflow, energy cost occurring in the nasopharynx was lower during Biflow</p></sec><sec><title>Clinical trial registration</title><p><uri xlink:href="http://cris.nih.go.kr/cris/">http://cris.nih.go.kr/cris/</uri>, identifier KCT0006100.</p></sec></abstract><kwd-group><kwd>high flow nasal cannula</kwd><kwd>Biflow</kwd><kwd>respiratory cycle</kwd><kwd>pressure-time product</kwd><kwd>concept trial</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Korea Medical Device Development Fund</institution><institution-id institution-id-type="doi">10.13039/100019266</institution-id></institution-wrap></funding-source></award-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health &#x00026; Welfare, the Ministry of Food and Drug Safety) (Project Number: 202011B26).</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="2"/><equation-count count="0"/><ref-count count="35"/><page-count count="8"/><word-count count="4832"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pulmonary Medicine</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>High-flow nasal cannula (HFNC) is widely employed in patients with hypoxemia and moderate hypercapnia (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>). By maintaining a continuous high flow during expiration, HFNC generates a low-to-moderate level of positive end-expiratory pressure (PEEP) in the nasopharynx (<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>). This mechanism enhances lung volume and improves oxygenation (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). The high inspiratory flow provided by HFNC reduces inspiratory work of breathing (WOB). However, during expiration, patients must overcome the resistance generated by the incoming high flow, potentially leading to increased WOB and disruption of the neural respiratory cycle (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B17" ref-type="bibr">17</xref>). We have therefore developed a bi-level high-flow system (Biflow), allowing separate adjustment rates for inspiration and expiration.</p><p>In the Biflow system, for instance, the inspiratory flow rate is set above the needs of the participants (e.g., 40 L/min), while the expiratory flow rate is set lower than the inspiratory flow rate (e.g., 20 L/min) to facilitate the participants&#x02019; own expiration. Our study aimed to explore the physiologic effects of Biflow in healthy individuals and compare them with those of conventional HFNC (Uniflow).</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and methods</title><p>This study was conducted at Asan Medical Center in Seoul, South Korea, a university-affiliated hospital, from April 2021 to June 2021. The study was approved by the Institutional Review Board (IRB), and informed consent was obtained from each participant (IRB No-2020-1901; approval date: December 23, 2020). The registration of the clinical trial was made prior to the enrollment of the first patient. The procedures were followed in accordance with the ethical standards of the responsible committee of ASAN Medical Center on human experimentation and the Helsinki Declaration of 1975.</p><sec id="S2.SS1"><title>Eligible individuals</title><p>This study was a proof of concept trial for Biflow in healthy individuals to evaluate the physiologic effects of the Biflow system. Inclusion criteria encompassed healthy adults aged 18 years or older with no history of respiratory or cardiovascular disease. Exclusion criteria included conditions precluding the application of a nasal respiratory cannula, such as previous facial surgery, trauma, deformity, or airway obstruction.</p></sec><sec id="S2.SS2"><title>Intervention</title><p>This prospective, controlled study employed a randomized block design mixing block sizes of 4 and 6 in healthy volunteers, initiating either Uniflow or Biflow mode (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Consort flow diagram.</p></caption><graphic xlink:href="fmed-12-1538832-g001" position="float"/></fig><p>For the Uniflow mode, three flow rates were examined: 30 L/min (U30), 40 L/min (U40) and 50 L/min (U50). In the Biflow mode, inspiratory flow rates were aligned with those of Uniflow, while expiratory (basal) flow rates varied: 10, 20, and 30 L/min. The resultant flow settings for Biflow were (inspiratory/expiratory): 30/10, 30/20, 40/10, 40/20, 40/30, 50/20, 50/30. Biflow 50/40 was excluded as most volunteers exhibited intolerance during the preliminary test. The phase transition between expiration and inspiration in the Biflow system relied on a &#x0201c;patient effort-dependent trigger.&#x0201d; The criteria for the initiation of inspiration were met when the nasopharyngeal pressure dropped by &#x02265; 0.4 cmH<sub>2</sub>O, accompanied by a simultaneous increase in flow rate by &#x02265; 1 L/min. Alternatively, expiration was triggered if the inspiratory phase exceeded the predefined time limit (6 s). However, the current version of the Biflow system failed to detect the inspiratory effort of the patient under conditions of relatively low bias flow (before the start of inspiration) or when the participant&#x02019;s respiratory effort was too weak. Owing to this technical constraint, the proportion of breaths delivered through the Biflow system ranged between 25 and 63% of all recorded breaths (<xref rid="F2" ref-type="fig">Figure 2</xref>). The sequence and duration of each flow setting were randomized and maintained for 3 min. Baseline recordings of spontaneous breathing were recorded for 5 mins before beginning the study protocol. Between Uniflow and Biflow, a 5-min washout period was allowed for the resumption of normal breathing (<xref rid="B18" ref-type="bibr">18</xref>).</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Airway pressure tracing (upper) and Bi-flow operating signal (lower). During Biflow, breath a was a failed operation, and breaths b and c were successful.</p></caption><graphic xlink:href="fmed-12-1538832-g002" position="float"/></fig></sec><sec id="S2.SS3"><title>Measurements</title><p>Physiologic parameters, including respiratory rates (RR), inspiratory:expiratory (I:E) ratio, heart rate (HR), transcutaneous CO<sub>2</sub> (tcCO<sub>2</sub>) and pulse oxygen saturation (SpO<sub>2</sub>), were systematically recorded at each minute of the study. Subjective comfort levels were evaluated using the modified Borg Scale (MBS) at the end of each setting. To compare end-expiratory lung volume, continuous electrical impedance tomography (EIT) data were collected throughout the study (<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>). EIT generates cross-sectional images depicting impedance distribution within electrically conductive objects, allowing for a semi-quantitative evaluation of static and dynamic lung volumes. Tidal impedance variation (TIV) and global inhomogeneity (GI) index were analyzed using EIT Data Analysis Tool version 6.3 and GI MATLAB Tool ver 3.0. End-expiratory lung impedance (EELI) data were processed using dedicated software Pulmovista Data Analysis Software ver 1.3.</p><p>To gauge the nasopharyngeal pressure of the participant, a thin PVC catheter (7 Fr) was inserted 9 cm deep in one of the nostrils of the participant. The pressure signal was recorded using LabVIEW (National Instruments Co., TX, United States), and subsequent numerical analyses were executed using MATLAB software (Mathworks Inc., MA, United States). &#x00394;Pexp (cmH<sub>2</sub>O) was defined as (peak pressure &#x02013; baseline pressure) during expiration, and &#x00394;Pinsp (cmH<sub>2</sub>O) as (baseline pressure &#x02013; lowest pressure) during inspiration. The nasal pressure-time produced (N-PTP), a proxy of energy cost (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>), was calculated by integrating <italic>P</italic><sub><italic>aw</italic></sub> with time: &#x0222b;(<italic>P</italic><sub><italic>aw</italic></sub>&#x02212;<italic>PEEP</italic>)<italic>dt</italic>. Inspiratory, expiratory, and total N-PTP were obtained (<xref rid="DS1" ref-type="supplementary-material">Supplementary Figure 1</xref>) (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Inspiration time and expiration time were also measured.</p></sec><sec id="S2.SS4"><title>Statistical analysis</title><p>All continuous variables are presented as median and interquartile range, while categorical variables are expressed as percentages. Wilcoxon signed-rank test was employed for continuous data, and Pearson&#x02019;s chi-squared test or Fisher&#x02019;s exact test for categorical data. Comparisons between Uniflow and Biflow parameters at the same inspiratory flow rate were conducted, employing pooled and matched analyses. All <italic>p</italic>-values were two-tailed, with statistical significance set at <italic>p</italic> &#x0003c; 0.05. All statistical analyses were performed using SPSS software (version 22.0; IBM Corporation, Somers, NY, United States).</p></sec></sec><sec sec-type="results" id="S3"><title>Results</title><p>We enrolled sixteen healthy participants, of whom all followed the protocol until completion. Among them, 12 cases acquired the full measurement data and were included in the analysis. The participant population comprised 58% males, and the mean age was 46.2 years. The median BMI was 22.1 (19.7&#x02013;25.5) kg/m<sup>2</sup>.</p><p>As the flow rate increased, RR decreased significantly during Uniflow settings compared with natural breathing; however, RR during the Biflow settings did not differ from the natural breathing. During the Uniflow settings, both inspiratory and expiratory times were prolonged compared with natural breathing. As the flow rate was increased during the Uniflow, the expiratory time was more elongated. During the Biflow settings, inspiratory time was prolonged, but expiratory time did not significantly differ from natural breathing. Expiratory time was shorter with the Biflow compared with Uniflow. The I:E ratio remained unchanged during Uniflow but increased during Biflow as the flow rate increased (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Change of synchronized respiratory parameters according to the flow setting.</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"/><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Setting</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">RR (/min)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Inspiratory time (sec)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Expiratory time (sec)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">I:E ratio</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Baseline</td><td valign="top" align="center" rowspan="1" colspan="1">Natural breathing</td><td valign="top" align="center" rowspan="1" colspan="1">15.6 (13.5&#x02013;17.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1.3 (1.1&#x02013;1.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2.3 (1.8&#x02013;2.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0.5&#x02013;0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 30</td><td valign="top" align="center" rowspan="1" colspan="1">U30</td><td valign="top" align="center" rowspan="1" colspan="1">13.5 (10.0&#x02013;15.8)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.7 (1.5&#x02013;2.2)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.9 (2.1&#x02013;4.0)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (0.5&#x02013;0.8)<xref rid="t1fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B30/10</td><td valign="top" align="center" rowspan="1" colspan="1">13.3 (12.0&#x02013;18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1.9 (1.6&#x02013;2.2)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.4 (1.9&#x02013;2.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.7&#x02013;1.0)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B30/20</td><td valign="top" align="center" rowspan="1" colspan="1">13.9 (13.1&#x02013;17.9)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.6 (1.3&#x02013;1.8)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.3 (1.9&#x02013;2.8)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (0.6&#x02013;0.9)<xref rid="t1fns1" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 40</td><td valign="top" align="center" rowspan="1" colspan="1">U40</td><td valign="top" align="center" rowspan="1" colspan="1">12.7 (9.1&#x02013;13.8)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.7 (1.5&#x02013;2.1)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.1 (2.7&#x02013;4.8)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0.5&#x02013;0.6)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/10</td><td valign="top" align="center" rowspan="1" colspan="1">13.0 (12.3&#x02013;14.7)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.9 (1.7&#x02013;2.5)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.5 (2.2&#x02013;3.0)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (0.7&#x02013;0.9)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/20</td><td valign="top" align="center" rowspan="1" colspan="1">16.4 (12.7&#x02013;18.2)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.5 (1.1&#x02013;2.1)<xref rid="t1fnd1" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.2 (1.9&#x02013;2.9)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.6 (0.5&#x02013;0.8)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/30</td><td valign="top" align="center" rowspan="1" colspan="1">13.7 (10.5&#x02013;14.2)<xref rid="t1fns2" ref-type="table-fn">**</xref><sup>,</sup><xref rid="t1fnd2" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.6 (1.5&#x02013;1.9)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fnd1" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.0 (2.7&#x02013;4.5)<xref rid="t1fns2" ref-type="table-fn">**</xref><sup>,</sup><xref rid="t1fnd2" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.6 (0.5&#x02013;0.6)<xref rid="t1fns1" ref-type="table-fn">**</xref><sup>,</sup><xref rid="t1fnd1" ref-type="table-fn"><sup>&#x02020;</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 50</td><td valign="top" align="center" rowspan="1" colspan="1">U50</td><td valign="top" align="center" rowspan="1" colspan="1">10.0 (9.4&#x02013;13.2)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.8 (1.6&#x02013;2.0)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.8 (2.7&#x02013;4.5)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.5(0.4&#x02013;0.6)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B50/20</td><td valign="top" align="center" rowspan="1" colspan="1">15.0 (12.9&#x02013;19.8)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.7 (1.3&#x02013;2.2)<xref rid="t1fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.4 (1.9&#x02013;3.1)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (0.6&#x02013;0.8)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B50/30</td><td valign="top" align="center" rowspan="1" colspan="1">14.2 (11.0&#x02013;16.6)<xref rid="t1fns2" ref-type="table-fn">**</xref><sup>,</sup><xref rid="t1fnd2" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.7 (1.5&#x02013;2.2)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fnd2" ref-type="table-fn"><sup>&#x02021;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.5 (2.0&#x02013;2.9)<xref rid="t1fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.7 (0.6&#x02013;0.9)<xref rid="t1fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t1fns2" ref-type="table-fn">**</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Data are expressed as median and IQR.</p></fn><fn id="t1fns1"><p>*<italic>P</italic>-value of &#x0003c; 0.05 compared with natural breathing,</p></fn><fn id="t1fns2"><p>**<italic>P</italic>-value of &#x0003c; 0.05 compared with Uniflow.</p></fn><fn id="t1fnd1"><p><sup>&#x02020;</sup><italic>P</italic>-value of &#x0003c; 0.05 compared with Biflow 40/10,</p></fn><fn id="t1fnd2"><p><sup>&#x02021;</sup><italic>P</italic>-value of &#x0003c; 0.05 compared with Biflow 40/20 or 50/20.</p></fn></table-wrap-foot></table-wrap><p>No significant differences were observed in HR and SpO<sub>2</sub> between the Unflow and the Biflow at the same inspiratory flow rate. The levels of tcCO<sub>2</sub> at B30/10, B40/10, and B40/20 were notably lower compared with natural breathing or the Uniflow settings (<xref rid="T2" ref-type="table">Table 2</xref>). The participants reported light dyspnea during both modes.</p><table-wrap position="float" id="T2"><label>TABLE 2</label><caption><p>Change in physiological variables according to the flow setting.</p></caption><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"/><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Setting</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">HR (/min)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">tcCO<sub>2</sub> (mmHg)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">SpO<sub>2</sub> (%)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">MBS</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Baseline</td><td valign="top" align="center" rowspan="1" colspan="1">Natural breathing</td><td valign="top" align="center" rowspan="1" colspan="1">72.0 (68.6&#x02013;85.8)</td><td valign="top" align="center" rowspan="1" colspan="1">38.8 (35.6&#x02013;41.2)</td><td valign="top" align="center" rowspan="1" colspan="1">97.8 (96.9&#x02013;98.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 30</td><td valign="top" align="center" rowspan="1" colspan="1">U30</td><td valign="top" align="center" rowspan="1" colspan="1">67.8 (65.9&#x02013;84.8)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">39.5 (36.1&#x02013;41.9)</td><td valign="top" align="center" rowspan="1" colspan="1">97.7 (97.2&#x02013;98.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0&#x02013;0.5)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B30/10</td><td valign="top" align="center" rowspan="1" colspan="1">68.9 (65.9&#x02013;87.0)</td><td valign="top" align="center" rowspan="1" colspan="1">37.4 (34.2&#x02013;41.0)<xref rid="t2fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.2&#x02013;99.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.4 (0&#x02013;0.9)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B30/20</td><td valign="top" align="center" rowspan="1" colspan="1">68.2 (66.6&#x02013;86.6)</td><td valign="top" align="center" rowspan="1" colspan="1">38.3 (35.0&#x02013;41.2)<xref rid="t2fnd1" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.2&#x02013;99.)</td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0&#x02013;0.5)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 40</td><td valign="top" align="center" rowspan="1" colspan="1">U40</td><td valign="top" align="center" rowspan="1" colspan="1">70.9 (66.6&#x02013;86.4)</td><td valign="top" align="center" rowspan="1" colspan="1">38.2 (36.1&#x02013;40.2)</td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.4&#x02013;98.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0&#x02013;0.5)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/10</td><td valign="top" align="center" rowspan="1" colspan="1">69.7 (66.3&#x02013;86.0)</td><td valign="top" align="center" rowspan="1" colspan="1">37.0 (34.2&#x02013;40.5)<xref rid="t2fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t2fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.0&#x02013;99.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0&#x02013;2.0)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/20</td><td valign="top" align="center" rowspan="1" colspan="1">69.5 (67.0&#x02013;84.7)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">37.7 (33.2&#x02013;40.6)<xref rid="t2fns1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="t2fns2" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (97.2&#x02013;99.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 (0&#x02013;1.8)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B40/30</td><td valign="top" align="center" rowspan="1" colspan="1">69.7 (67.1&#x02013;82.3)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">39.2 (35.9&#x02013;40.8)<xref rid="t2fnd1" ref-type="table-fn"><sup>&#x02020;</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.2 (97.0&#x02013;99.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 (0&#x02013;1.6)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Flow 50</td><td valign="top" align="center" rowspan="1" colspan="1">U50</td><td valign="top" align="center" rowspan="1" colspan="1">71.0 (68.0&#x02013;87.7)</td><td valign="top" align="center" rowspan="1" colspan="1">37.9 (36.0&#x02013;40.2)</td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (96.9&#x02013;98.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.8 (0.5&#x02013;1.8)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B50/20</td><td valign="top" align="center" rowspan="1" colspan="1">68.8 (66.1&#x02013;82.2)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">37.1 (33.6&#x02013;39.9)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (96.9&#x02013;98.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.5 (0.1&#x02013;2.0)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">B50/30</td><td valign="top" align="center" rowspan="1" colspan="1">71.7 (67.7&#x02013;82.2)</td><td valign="top" align="center" rowspan="1" colspan="1">36.6 (33.9&#x02013;39.8)<xref rid="t2fns1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">98.0 (96.9&#x02013;98.7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 (0&#x02013;1.6)<xref rid="t2fns1" ref-type="table-fn">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Data are expressed as median and IQR.</p></fn><fn id="t2fns1"><p>*<italic>P</italic>-value of &#x0003c; 0.05 compared with natural breathing,</p></fn><fn id="t2fns2"><p>**<italic>P</italic>-value of &#x0003c; 0.05 compared with Uniflow.</p></fn><fn id="t2fnd1"><p><sup>&#x02020;</sup><italic>P</italic>-value of &#x0003c; 0.05 compared with Biflow (30/10 or 40/10).</p></fn></table-wrap-foot></table-wrap><sec id="S3.SS1"><title>Nasal pressure-time product</title><p>Expiratory time was shorter during the Biflow than during the Uniflow (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="F3" ref-type="fig">Figure 3a</xref>). Changes in the nasopharyngeal pressures during the Biflow as compared with the Uniflow are presented in <xref rid="DS1" ref-type="supplementary-material">Supplementary Table 1</xref>. Inspiratory N-PTP (<xref rid="F3" ref-type="fig">Figure 3b</xref>) and expiratory N-PTP (<xref rid="F3" ref-type="fig">Figure 3c</xref>) were lower during Biflow compared with Uniflow. Total N-PTP was also lower during Biflow than Uniflow (<xref rid="F3" ref-type="fig">Figure 3d</xref>). The decrease in N-PTP was most prominent at B40/20 (inspiratory flow 40 L/min and expiratory flow 20 L/min).</p><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Changes in expiratory time and N-PTP <bold>(a)</bold> Change of expiration time of Biflow compared to Uniflow <bold>(b)</bold> Change of inspiratory PTP of Biflow compared to Uniflow <bold>(c)</bold> Change of expiratory PTP of Biflow compared to Uniflow <bold>(d)</bold> Change of total PTP of Biflow compared to Uniflow <italic>P</italic>-value of &#x0003c;0.05 compared with Uniflow, *<italic>P</italic>-value of &#x0003c;0.05 between Biflow settings. PTPinsp, inspiratory nasal pressure time product; PTPexp, expiratory nasal pressure time product; PTPtotal, total nasal pressure time product; U, Uniflow; B, Biflow.</p></caption><graphic xlink:href="fmed-12-1538832-g003" position="float"/></fig></sec><sec id="S3.SS2"><title>Electrical impedance tomography measurements</title><p>TIV, EELI and V/D ratio increased in both Uniflow and Biflow modes compared with natural breathing. However, there were no significant differences observed between the two modes (<xref rid="F4" ref-type="fig">Figure 4</xref>). GI index exhibited a decrease in B40/10, B40/20, and B50/20 compared with natural breathing.</p><fig position="float" id="F4"><label>FIGURE 4</label><caption><p>Changes in TIV, GI index, EELI, and V/D ratio of EELI <bold>(a)</bold> Comparison of TIV among natural breathing, Uniflow and Biflow settings <bold>(b)</bold> Comparison of GI Index among natural breathing, Uniflow and Biflow settings <bold>(c)</bold> Comparison of EELI among natural breathing, Uniflow and Biflow settings <bold>(d)</bold> Comparison of V/D ratio among natural breathing, Uniflow and Biflow settings <italic>P</italic>-value of &#x0003c;0.05 compared with natural breathing, *<italic>P</italic>-value of &#x0003c;0.05 between Biflow settings. TIV, tidal impedance variation; GI, global inhomogeneity; EELI, end-expiratory lung impedance; V/D ratio, ventral/dorsal ratio; U, Uniflow; B, Biflow.</p></caption><graphic xlink:href="fmed-12-1538832-g004" position="float"/></fig></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>This study was designed as an exploratory trial to evaluate the Biflow system in healthy individuals. Compared with conventional HFNC (Uniflow), Biflow demonstrated a less substantial decrease in respiratory rate. During Uniflow, as the flow rate increased, the respiratory rate exhibited a stepwise decrease compared with natural breathing, while both inspiratory and expiratory time were elongated. However, during Biflow, the decrease in respiratory rate was less pronounced, and the expiratory time was preserved, resembling the pattern observed in the natural breathing of the participants. Compared with Uniflow, the N-PTP during both inspiration and expiration was lower with Biflow. These findings suggest that the energy dissipated in the nasopharynx during breathing was reduced with the Biflow compared with Uniflow. Interestingly, the lower expiratory N-PTP during Biflow was attributed to the decreased expiratory time compared with Uniflow, per the N-PTP formula (integration of pressure change and time). Conversely, the lower inspiratory N-PTP during Biflow was attributed to an attenuated pressure change during the inspiratory phase compared with Uniflow. Physiologic data such as HR, BP, SpO<sub>2</sub> and EELI, were similar between the two HFNC systems in the participants. The tcCO<sub>2</sub> levels during Biflow at flow trials 30 and 40 were lower compared with natural breathing or Uniflow. We observed a slight decrease in heart rate during both Uniflow and Biflow compared to natural breathing. This finding likely reflects reduced work of breathing due to high-flow oxygen support (<xref rid="B26" ref-type="bibr">26</xref>) or changes in vagal tone resulting from comfortable breathing pattern (<xref rid="B27" ref-type="bibr">27</xref>). The changes in the heart rate during both Uniflow and Biflow were modest (approximately 2-3 beats/min) and were similar between the two modes.</p><p>The use of HFNC, referred to as Uniflow in our study, has increased exponentially over the past few years, particularly during the COVID-19 pandemic (<xref rid="B1" ref-type="bibr">1</xref>). The adoption of HFNC helped reduce intubation rates for patients with acute hypoxic respiratory failure and prevent post-extubation respiratory failure (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Improved patient outcomes associated with HFNC are due to physiological effects, such as improvement in oxygenation (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B28" ref-type="bibr">28</xref>), efficient ventilation (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B29" ref-type="bibr">29</xref>), avoidance of patient self-inflicted lung injury, and improvement in patient comfort and tolerance (<xref rid="B30" ref-type="bibr">30</xref>). For maximal dead space washout and PEEP-like effect, clinical use of the flow rate during HFNC ranges up to 40&#x02013;50 L/min. Dysart et al. suggested that matching HFNC with inspiratory demand may attenuate nasopharyngeal resistance and lead to a reduction of WOB. Despite these benefits, this excessive range of gas flow may impose additional WOB to overcome the greater jet flow for expiration (<xref rid="B31" ref-type="bibr">31</xref>) and disrupt patients&#x02019; own respiratory cycle. HFNC has been widely reported to affect respiratory rate, tidal volume, and I:E ratio (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Our study also showed that HFNC led to a decrease in respiratory rate and an increase in inspiratory time and expiratory time compared with natural breathing. However, the Biflow system, characterized by alternating flow rates synchronized with the respiratory cycle&#x02014;specifically, a reduction of flow during the expiratory phase&#x02014;mitigated the bradypnea effect associated with high flow and increased the I:E ratio. Notably, inspiratory pressure changes in the nasopharynx during the Bioflow were attenuated and inspiratory N-PTP was consequently lower compared with the Uniflow. The combination of reduced pressure changes and increased I:E ratio, particularly with a reduced expiration time with the Biflow mode, suggests a potential reduction in the energy cost per breathing cycle.</p><p>As the PEEP-like effect during HFNC is known to be proportional to flow rate (<xref rid="B18" ref-type="bibr">18</xref>), the lower flow rate during expiration with the Biflow may be disadvantageous in terms of the PEEP-like effect or end-expiratrory lung volume. In our study, the expiratory nasopharyngeal pressure during the Biflow was lower than Uniflow by 27.2-83.7 % (<xref rid="DS1" ref-type="supplementary-material">Supplementary Table 1</xref>). Whereas, the EELI (surrogate for volume) as assessed by EIT was not different between Uniflow and Biflow (<xref rid="F4" ref-type="fig">Figure 4</xref>). It seems, therefore, premature to predict the overall effect of the reduced expiratory nasopharyngeal pressure during Biflow in diverse respiratory patients.</p><p>Besides oxygenation aid, the HFNC is used as a ventilation support for mild-moderate hypercapnia (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). In the Biflow system, the augmentation of gas flow during inspiration is analogous to the pressure augmentation occurring with BiPAP, a noninvasive ventilation method. BiPAP necessitates a mask or helmet to create a closed circuit, which is often the culprit of treatment failure. Unlike BiPAP, Biflow operates without the need for these artificial interfaces. In this context, Biflow may be regarded as an &#x02018;open&#x02019; system for noninvasive ventilation support, although the level of support may be lower than with BiPAP.</p><p>Our study has a few limitations. First, this is a single-center study with a small number (twelve) of participants. However, as this was the first study examining the physiological effects of the Biflow, we determined the sample size based on existing studies of HFNC. Studies by Ritchie et al. (<xref rid="B34" ref-type="bibr">34</xref>), Parke et al. (<xref rid="B18" ref-type="bibr">18</xref>), and Groves and Tobin (<xref rid="B35" ref-type="bibr">35</xref>) used 10-15 subjects to examine various physiological parameters of HFNC. Second, breath synchronization during the Biflow system was not technically perfect. For the operation of the Biflow, both inspiratory and expiratory efforts of the participant should be detected. The current Biflow system failed to detect the inspiration of the participant when the bias flow rate (before the start of inspiration) was relatively low (e.g., 10 L/min) or when the breathing effort was too weak. This technical limitation is inherently associated with the open nature of the Biflow system and requires improvement before clinical application. Finally, we did not investigate the long-term effects of the Biflow. Prior to establishing any clinical benefit, the Biflow needs long-term application in patients with various respiratory pathophysiologies.</p></sec><sec sec-type="conclusion" id="S5"><title>Conclusion</title><p>Compared with the current HFNC (singular flow throughout the respiratory cycle), the Biflow HFNC in healthy individuals showed less disturbance of participants&#x02019; respiratory cycle and resulted in a lower energy cost occurring in the nasopharynx.</p></sec></body><back><fn-group><title>Abbreviations</title><fn fn-type="abbr"><p>Biflow, Bi-level high-flow system; EELI, End-expoiratory lung impedance; EIT, Electrical impedance tomography; GI, Global inhomogeneity; HFNC, High-flow nasal cannula; HR, Heart rate; I:E, Inspiratory:expiratory; MBS, Modified Borg Scale; N-PTP, Nasopharyngeal pressure-time product; PEEP, Positive end-expiratory pressure; RR, Respiratory rates; SpO<sub>2</sub>, Pulse oxygen saturation; tcCO<sub>2</sub>, Transcutaneous carbon dioxide; TIV, Tidal impedance variation; WOB, Work of breathing.</p></fn></fn-group><sec sec-type="data-availability" id="S6"><title>Data availability statement</title><p>The original contributions presented in this study are included in this article/<xref rid="DS1" ref-type="supplementary-material">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="S7"><title>Ethics statement</title><p>The studies involving humans were approved by Institutional Review Board of Asan Medical Center (IRB No-2020-1901). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></sec><sec sec-type="author-contributions" id="S8"><title>Author contributions</title><p>JH: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. WS: Data curation, Investigation, Methodology, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. JA: Investigation, Software, Supervision, Validation, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. SL: Investigation, Methodology, Supervision, Validation, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. HS: Investigation, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. GS: Investigation, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. EK: Investigation, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. MJ: Investigation, Supervision, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. C-ML: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="S10"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="S11"><title>Generative AI statement</title><p>The authors declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="S12"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="S13"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2025.1538832/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmed.2025.1538832/full#supplementary-material</ext-link></p><supplementary-material id="DS1" position="float" content-type="local-data"><media xlink:href="Data_Sheet_1.pdf"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papoutsi</surname><given-names>E</given-names></name><name><surname>Giannakoulis</surname><given-names>V</given-names></name><name><surname>Xourgia</surname><given-names>E</given-names></name><name><surname>Routsi</surname><given-names>C</given-names></name><name><surname>Kotanidou</surname><given-names>A</given-names></name><name><surname>Siempos</surname><given-names>I</given-names></name></person-group>. <article-title>Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: A systematic review and meta-analysis of non-randomized cohort studies.</article-title>
<source><italic>Crit Care.</italic></source> (<year>2021</year>) <volume>25</volume>:<fpage>121</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-021-03540-6</pub-id>
<pub-id pub-id-type="pmid">33766109</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochwerg</surname><given-names>B</given-names></name><name><surname>Granton</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Helviz</surname><given-names>Y</given-names></name><name><surname>Einav</surname><given-names>S</given-names></name><name><surname>Frat</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: A systematic review and meta-analysis.</article-title>
<source><italic>Intensive Care Med.</italic></source> (<year>2019</year>) <volume>45</volume>:<fpage>563</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-019-05590-5</pub-id>
<pub-id pub-id-type="pmid">30888444</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernando</surname><given-names>S</given-names></name><name><surname>Tran</surname><given-names>A</given-names></name><name><surname>Sadeghirad</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Brodie</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Noninvasive respiratory support following extubation in critically ill adults: A systematic review and network meta-analysis.</article-title>
<source><italic>Intensive Care Med.</italic></source> (<year>2022</year>) <volume>48</volume>:<fpage>137</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-021-06581-1</pub-id>
<pub-id pub-id-type="pmid">34825256</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Shuai</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>High-flow nasal cannula oxygen therapy versus non-invasive ventilation for AECOPD patients after extubation: A systematic review and meta-analysis of randomized controlled trials.</article-title>
<source><italic>Int J Chron Obstruct Pulmon Dis.</italic></source> (<year>2022</year>) <volume>17</volume>:<fpage>1987</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.2147/COPD.S375107</pub-id>
<pub-id pub-id-type="pmid">36065316</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>D</given-names></name><name><surname>Walline</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: A multicenter, randomized controlled trial.</article-title>
<source><italic>Crit Care.</italic></source> (<year>2020</year>) <volume>24</volume>:<fpage>489</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-020-03214-9</pub-id>
<pub-id pub-id-type="pmid">32762701</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikata</surname><given-names>Y</given-names></name><name><surname>Onodera</surname><given-names>M</given-names></name><name><surname>Oto</surname><given-names>J</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name></person-group>. <article-title>FIO2 in an adult model simulating high-flow nasal cannula therapy.</article-title>
<source><italic>Respir Care.</italic></source> (<year>2017</year>) <volume>62</volume>:<fpage>193</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.04963</pub-id>
<pub-id pub-id-type="pmid">27879385</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>B</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group>. <article-title>Factors affecting FiO2 and PEEP during high-flow nasal cannula oxygen therapy: A bench study.</article-title>
<source><italic>Clin Respir J.</italic></source> (<year>2019</year>) <volume>13</volume>:<fpage>758</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1111/crj.13087</pub-id>
<pub-id pub-id-type="pmid">31465634</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebbink</surname><given-names>R</given-names></name><name><surname>Duiverman</surname><given-names>M</given-names></name><name><surname>Wijkstra</surname><given-names>P</given-names></name><name><surname>Hagmeijer</surname><given-names>R</given-names></name></person-group>. <article-title>Upper airway pressure distribution during nasal high-flow therapy.</article-title>
<source><italic>Med Eng Phys.</italic></source> (<year>2022</year>) <volume>104</volume>:<fpage>103805</fpage>. <pub-id pub-id-type="doi">10.1016/j.medengphy.2022.103805</pub-id>
<pub-id pub-id-type="pmid">35641081</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Weng</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Positive end-expiratory pressure effect of 3 high-flow nasal cannula devices.</article-title>
<source><italic>Respir Care.</italic></source> (<year>2017</year>) <volume>62</volume>:<fpage>888</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.05337</pub-id>
<pub-id pub-id-type="pmid">28442633</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>K</given-names></name><name><surname>Ellington</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Stanberry</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>DiBlasi</surname><given-names>R</given-names></name></person-group>. <article-title>Effect of high-flow nasal cannula on expiratory pressure and ventilation in infant, pediatric, and adult models.</article-title>
<source><italic>Respir Care.</italic></source> (<year>2018</year>) <volume>63</volume>:<fpage>147</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.05728</pub-id>
<pub-id pub-id-type="pmid">29066588</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>C</given-names></name><name><surname>Geoghegan</surname><given-names>P</given-names></name><name><surname>Spence</surname><given-names>C</given-names></name><name><surname>Jermy</surname><given-names>M</given-names></name></person-group>. <article-title>Modelling nasal high flow therapy effects on upper airway resistance and resistive work of breathing.</article-title>
<source><italic>Respir Physiol Neurobiol.</italic></source> (<year>2018</year>) <volume>254</volume>:<fpage>23</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2018.03.014</pub-id>
<pub-id pub-id-type="pmid">29635072</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onodera</surname><given-names>Y</given-names></name><name><surname>Akimoto</surname><given-names>R</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Nakane</surname><given-names>M</given-names></name><name><surname>Kawamae</surname><given-names>K</given-names></name></person-group>. <article-title>A high-flow nasal cannula system with relatively low flow effectively washes out CO2 from the anatomical dead space in a sophisticated respiratory model made by a 3D printer.</article-title>
<source><italic>Intensive Care Med Exp.</italic></source> (<year>2018</year>) <volume>6</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/s40635-018-0172-7</pub-id>
<pub-id pub-id-type="pmid">29546563</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Katz</surname><given-names>I</given-names></name><name><surname>Pichelin</surname><given-names>M</given-names></name><name><surname>Caillibotte</surname><given-names>G</given-names></name><name><surname>Finlay</surname><given-names>W</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name></person-group>. <article-title>High flow nasal cannula: Influence of gas type and flow rate on airway pressure and CO2 clearance in adult nasal airway replicas.</article-title>
<source><italic>Clin Biomech.</italic></source> (<year>2019</year>) <volume>65</volume>:<fpage>73</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiomech.2019.04.004</pub-id>
<pub-id pub-id-type="pmid">30991233</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu&#x000e9;rin</surname><given-names>C</given-names></name><name><surname>Cour</surname><given-names>M</given-names></name><name><surname>Degivry</surname><given-names>F</given-names></name><name><surname>Argaud</surname><given-names>L</given-names></name><name><surname>Louis</surname><given-names>BA</given-names></name></person-group>. <article-title>Bench comparison of the effect of high-flow oxygen devices on work of breathing.</article-title>
<source><italic>Respir Care.</italic></source> (<year>2022</year>) <volume>67</volume>:<fpage>1129</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.09889</pub-id>
<pub-id pub-id-type="pmid">35790397</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Fink</surname><given-names>J</given-names></name><name><surname>Reed</surname><given-names>B</given-names></name><name><surname>Roca</surname><given-names>O</given-names></name><name><surname>Dhand</surname><given-names>R</given-names></name></person-group>. <article-title>Optimizing high-flow nasal cannula flow settings in adult hypoxemic patients based on peak inspiratory flow during tidal breathing.</article-title>
<source><italic>Ann Intensive Care.</italic></source> (<year>2021</year>) <volume>11</volume>:<fpage>164</fpage>. <pub-id pub-id-type="doi">10.1186/s13613-021-00949-8</pub-id>
<pub-id pub-id-type="pmid">34837553</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duprez</surname><given-names>F</given-names></name><name><surname>de Terwangne</surname><given-names>C</given-names></name><name><surname>Bellemans</surname><given-names>V</given-names></name><name><surname>Poncin</surname><given-names>W</given-names></name><name><surname>Reychler</surname><given-names>G</given-names></name><name><surname>Sorgente</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: An experimental adult bench model.</article-title>
<source><italic>J Clin Monit Comput.</italic></source> (<year>2022</year>) <volume>36</volume>:<fpage>1441</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s10877-021-00784-z</pub-id>
<pub-id pub-id-type="pmid">34877626</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>G</given-names></name><name><surname>Cox</surname><given-names>C</given-names></name><name><surname>Shaffer</surname><given-names>T</given-names></name></person-group>. <article-title>Nasal cannula, CPAP, and high-flow nasal cannula: Effect of flow on temperature, humidity, pressure, and resistance.</article-title>
<source><italic>Biomed Instrum Technol.</italic></source> (<year>2011</year>) <volume>45</volume>:<fpage>69</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.2345/0899-8205-45.1.69</pub-id>
<pub-id pub-id-type="pmid">21322815</pub-id>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parke</surname><given-names>R</given-names></name><name><surname>McGuinness</surname><given-names>S</given-names></name><name><surname>Eccleston</surname><given-names>M</given-names></name></person-group>. <article-title>Nasal high-flow therapy delivers low level positive airway pressure.</article-title>
<source><italic>Br J Anaesth.</italic></source> (<year>2009</year>) <volume>103</volume>:<fpage>886</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aep280</pub-id>
<pub-id pub-id-type="pmid">19846404</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frerichs</surname><given-names>I</given-names></name></person-group>. <article-title>Electrical impedance tomography (EIT) in applications related to lung and ventilation: A review of experimental and clinical activities.</article-title>
<source><italic>Physiol Meas.</italic></source> (<year>2000</year>) <volume>21</volume>:<fpage>R1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1088/0967-3334/21/2/201</pub-id>
<pub-id pub-id-type="pmid">10847187</pub-id>
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulletz</surname><given-names>S</given-names></name><name><surname>van Genderingen</surname><given-names>H</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Zick</surname><given-names>G</given-names></name><name><surname>Sch&#x000e4;dler</surname><given-names>D</given-names></name><name><surname>Scholz</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Comparison of different methods to define regions of interest for evaluation of regional lung ventilation by EIT.</article-title>
<source><italic>Physiol Meas.</italic></source> (<year>2006</year>) <volume>27</volume>:<fpage>S115</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1088/0967-3334/27/5/S10</pub-id>
<pub-id pub-id-type="pmid">16636403</pub-id>
</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Yun</surname><given-names>P</given-names></name><name><surname>Kuo</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Comparison of different functional EIT approaches to quantify tidal ventilation distribution.</article-title>
<source><italic>Physiol Meas.</italic></source> (<year>2018</year>) <volume>39</volume>:<fpage>01NT01</fpage>. <pub-id pub-id-type="doi">10.1088/1361-6579/aa9eb4</pub-id>
<pub-id pub-id-type="pmid">29192891</pub-id>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzia</surname><given-names>E</given-names></name><name><surname>Lindner</surname><given-names>K</given-names></name><name><surname>Witt</surname><given-names>S</given-names></name><name><surname>Schirmer</surname><given-names>U</given-names></name><name><surname>Lange</surname><given-names>H</given-names></name><name><surname>Stenz</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Pressure-time product and work of breathing during biphasic continuous positive airway pressure and assisted spontaneous breathing.</article-title>
<source><italic>Am J Respir Crit Care Med.</italic></source> (<year>1994</year>) <volume>150</volume>:<fpage>904</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.150.4.7921461</pub-id>
<pub-id pub-id-type="pmid">7921461</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Montecchia</surname><given-names>F</given-names></name><name><surname>Luciani</surname><given-names>S</given-names></name><name><surname>Cicchetti</surname><given-names>R</given-names></name><name><surname>Grossi</surname><given-names>R</given-names></name><name><surname>Midulla</surname><given-names>F</given-names></name><name><surname>Moretti</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Pharyngeal and esophageal pressure measurements to evaluate respiratory mechanics in infants on high flow nasal cannula: A feasibility study.</article-title>
<source><italic>Proceedings of the IEEE International Symposium on Medical Measurements and Applications (MeMeA).</italic></source>
<publisher-loc>Turin</publisher-loc>: <publisher-name>IEEE</publisher-name> (<year>2015</year>).</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinnan</surname><given-names>D</given-names></name><name><surname>Truwit</surname><given-names>J</given-names></name></person-group>. <article-title>Clinical review: Respiratory mechanics in spontaneous and assisted ventilation.</article-title>
<source><italic>Crit Care.</italic></source> (<year>2005</year>) <volume>9</volume>:<fpage>472</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1186/cc3516</pub-id>
<pub-id pub-id-type="pmid">16277736</pub-id>
</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natalini</surname><given-names>G</given-names></name><name><surname>Marchesini</surname><given-names>M</given-names></name><name><surname>Tessadrelli</surname><given-names>A</given-names></name><name><surname>Rosano</surname><given-names>A</given-names></name><name><surname>Candiani</surname><given-names>A</given-names></name><name><surname>Bernardini</surname><given-names>A</given-names></name></person-group>. <article-title>Effect of breathing pattern on the pressure-time product calculation.</article-title>
<source><italic>Acta Anaesthesiol Scand.</italic></source> (<year>2004</year>) <volume>48</volume>:<fpage>642</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.0001-5172.2004.00377.x</pub-id>
<pub-id pub-id-type="pmid">15101863</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Albuainain</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Roca</surname><given-names>O</given-names></name><name><surname>Mauri</surname><given-names>T</given-names></name></person-group>. <article-title>The effects of flow settings during high-flow nasal cannula support for adult subjects: A systematic review.</article-title>
<source><italic>Crit Care.</italic></source> (<year>2023</year>) <volume>27</volume>:<fpage>78</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-023-04361-5</pub-id>
<pub-id pub-id-type="pmid">36855198</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrer</surname><given-names>P</given-names></name><name><surname>Gevirtz</surname><given-names>R</given-names></name></person-group>. <article-title>Heart rate variability biofeedback: How and why does it work?</article-title>
<source><italic>Front Psychol.</italic></source> (<year>2014</year>) <volume>5</volume>:<fpage>756</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2014.00756</pub-id>
<pub-id pub-id-type="pmid">25101026</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>T</given-names></name><name><surname>Alban</surname><given-names>L</given-names></name><name><surname>Turrini</surname><given-names>C</given-names></name><name><surname>Cambiaghi</surname><given-names>B</given-names></name><name><surname>Carlesso</surname><given-names>E</given-names></name><name><surname>Taccone</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: Effects of increasing flow rates.</article-title>
<source><italic>Intensive Care Med.</italic></source> (<year>2017</year>) <volume>43</volume>:<fpage>1453</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-017-4890-1</pub-id>
<pub-id pub-id-type="pmid">28762180</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorme</surname><given-names>M</given-names></name><name><surname>Bouchard</surname><given-names>P</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Simard</surname><given-names>S</given-names></name><name><surname>Lellouche</surname><given-names>F</given-names></name></person-group>. <article-title>Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure.</article-title>
<source><italic>Crit Care Med.</italic></source> (<year>2017</year>) <volume>45</volume>:<fpage>1981</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0000000000002693</pub-id>
<pub-id pub-id-type="pmid">28857852</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goligher</surname><given-names>E</given-names></name><name><surname>Slutsky</surname><given-names>A</given-names></name></person-group>. <article-title>Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in hypoxemic respiratory failure.</article-title>
<source><italic>Am J Respir Crit Care Med.</italic></source> (<year>2017</year>) <volume>195</volume>:<fpage>1128</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201701-0006ED</pub-id>
<pub-id pub-id-type="pmid">28459344</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dysart</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>T</given-names></name><name><surname>Wolfson</surname><given-names>M</given-names></name><name><surname>Shaffer</surname><given-names>T</given-names></name></person-group>. <article-title>Research in high flow therapy: Mechanisms of action.</article-title>
<source><italic>Respir Med.</italic></source> (<year>2009</year>) <volume>103</volume>:<fpage>1400</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.rmed.2009.04.007</pub-id>
<pub-id pub-id-type="pmid">19467849</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000e4;unlich</surname><given-names>J</given-names></name><name><surname>Beyer</surname><given-names>D</given-names></name><name><surname>Mai</surname><given-names>D</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name><name><surname>Seyfarth</surname><given-names>H</given-names></name><name><surname>Wirtz</surname><given-names>H</given-names></name></person-group>. <article-title>Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients.</article-title>
<source><italic>Respiration.</italic></source> (<year>2013</year>) <volume>85</volume>:<fpage>319</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1159/000342027</pub-id>
<pub-id pub-id-type="pmid">23128844</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corley</surname><given-names>A</given-names></name><name><surname>Caruana</surname><given-names>L</given-names></name><name><surname>Barnett</surname><given-names>A</given-names></name><name><surname>Tronstad</surname><given-names>O</given-names></name><name><surname>Fraser</surname><given-names>J</given-names></name></person-group>. <article-title>Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients.</article-title>
<source><italic>Br J Anaesth.</italic></source> (<year>2011</year>) <volume>107</volume>:<fpage>998</fpage>&#x02013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aer265</pub-id>
<pub-id pub-id-type="pmid">21908497</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Gerard</surname><given-names>C</given-names></name><name><surname>Hockey</surname><given-names>H</given-names></name></person-group>. <article-title>Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures.</article-title>
<source><italic>Anaesth Intensive Care.</italic></source> (<year>2011</year>) <volume>39</volume>:<fpage>1103</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1177/0310057X1103900620</pub-id>
<pub-id pub-id-type="pmid">22165366</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groves</surname><given-names>N</given-names></name><name><surname>Tobin</surname><given-names>A</given-names></name></person-group>. <article-title>High flow nasal oxygen generates positive airway pressure in adult volunteers.</article-title>
<source><italic>Aust Crit Care.</italic></source> (<year>2007</year>) <volume>20</volume>:<fpage>126</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.aucc.2007.08.001</pub-id>
<pub-id pub-id-type="pmid">17931878</pub-id>
</mixed-citation></ref></ref-list></back></article>